Bard Peripheral Vascular recalls 101 guiding sheaths

Bard Peripheral Vascular recalled 101 of its Halo One Thin-Walled guiding sheaths, which are used to introduce and/or guide interventional and diagnostic devices into veins and arteries.

The FDA announced the recall in a news release on Jan. 30. Bard found that the sheath body could separate from the sheath hub when clinicians remove the device from patients’ legs. The company also said the sheath could kink and the tip could become damaged.

Bard sent a recall notification to customers on Jan. 10 telling them to stop using and distributing the affected products. The recalled products were manufactured from April 12 to July 7, 2016, and were distributed from June 24 to July 12, 2016.

The 101 devices recalled were distributed in Arizona, Florida, Kansas, Louisiana, Maine, Michigan, Missouri, Nevada, New Hampshire, New York, Ohio, Texas, Utah and Washington.

Tim Casey,

Executive Editor

Tim Casey joined TriMed Media Group in 2015 as Executive Editor. For the previous four years, he worked as an editor and writer for HMP Communications, primarily focused on covering managed care issues and reporting from medical and health care conferences. He was also a staff reporter at the Sacramento Bee for more than four years covering professional, college and high school sports. He earned his undergraduate degree in psychology from the University of Notre Dame and his MBA degree from Georgetown University.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.